Drugs for Treatment of Erectile Dysfunction

Vardanyan, Ruben; Hruby, Victor J.

doi:10.1016/b978-0-12-411492-0.00038-9

Cited by 1 publication

(1 citation statement)

References 122 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One limitation of this study is that the antagonists used in the mechanism studies were administered in single doses and these agents have potential to act on other receptors than the targeted ones. For example, phentolamine, which shows its primary pharmacological effect by antagonizing α-adrenergic receptors, has also been reported to block serotonergic receptors and potassium channels and to inhibit histamine release from mast cells [ 49 , 50 , 51 , 52 ]. Moreover, NAN-190, a selective 5-HT 1A receptor antagonist, has been shown to block α 2 -adrenergic receptors in rodents [ 53 ].…”

Section: Discussionmentioning

confidence: 99%

5-HT1A Serotonergic, α-Adrenergic and Opioidergic Receptors Mediate the Analgesic Efficacy of Vortioxetine in Mice

et al. 2021

View full text Add to dashboard Cite

Vortioxetine is a multimodal antidepressant drug that affects several brain neurochemicals and has the potential to induce various pharmacological effects on the central nervous system. Therefore, we investigated the centrally mediated analgesic efficacy of this drug and the mechanisms underlying this effect. Analgesic activity of vortioxetine (5, 10 and 20 mg/kg, p.o.) was examined by tail-clip, tail-immersion and hot-plate tests. Motor performance of animals was evaluated using Rota-rod device. Time course measurements (30–180 min) showed that vortioxetine (10 and 20 mg/kg) administrations significantly increased the response latency, percent maximum possible effect and area under the curve values in all of the nociceptive tests. These data pointed out the analgesic effect of vortioxetine on central pathways carrying acute thermal and mechanical nociceptive stimuli. Vortioxetine did not alter the motor coordination of mice indicating that the analgesic activity of this drug was specific. In mechanistic studies, pre-treatments with p-chlorophenylalanine (serotonin-synthesis inhibitor), NAN-190 (serotonin 5-HT1A receptor antagonist), α-methyl-para-tyrosine (catecholamine-synthesis inhibitor), phentolamine (non-selective α-adrenoceptor blocker), and naloxone (non-selective opioid receptor blocker) antagonised the vortioxetine-induced analgesia. Obtained findings indicated that vortioxetine-induced analgesia is mediated by 5-HT1A serotonergic, α-adrenergic and opioidergic receptors, and contributions of central serotonergic and catecholaminergic neurotransmissions are critical for this effect.

show abstract

Section: Discussionmentioning

confidence: 99%